Skip to content
akaturk Academic measurement

Article detail · 2024

Role of cannabinoid CB1 receptors in the proconvulsant effect of Apelin-13 on penicillin-induced epileptiform activity

Journal

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY

ISSN 0019-5189

The ISSN points to another catalog journal; the name is from the YÖKSİS record.

YÖKSİS OpenAlex Open access · diamond SJR Q3 JCR Q4 Citations 0 Percentile 3.3% FWCI 0.0
Year
2024
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY
  • Catalog match (ISSN) Indian Journal of Experimental Biology (discontinued)
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

Epilepsy is a widespread neurological disorder. Many neurotransmitters, neuropeptides and neuromodulators have a significant role in the epileptic activity. Apelin-13 and cannabinoid CB1 receptor agonist and antagonist have an effect in the penicillin model of epilepsy. The relationship between apelin and epilepsy, and the apelin-cannabinoid relationship in epilepsy is still not well understood. Thus, this study focuses on the relationship between apelin-13 and CB1 receptor in experimental model of epilepsy. Penicillin injection was given intracortically (i.c.) for the development of epileptic seizures. Ninety-one male Wistar rats were divided into 13 groups. CB1 receptor agonist ACEA (7.5 µg, intracerebroventricularly, icv) and antagonist AM-251 (0.25 µg and 0.125 µg, icv) were administered to three different groups, two different doses of apelin-13 (5 µg and 15 µg, icv) were applied and the interactions between these five groups of substances were evaluated. Both apelin-13 (15 µg) and AM-251 (0.25 µg) raised the spike frequency of epileptiform activity separately. Application of apelin-13 + AM-251 also increased the spike frequency of epileptiform activity beginning in the 30 min after apelin-13 application. When the non-effective dose of AM-251 and the effective dose of apelin-13 were administered together, epileptic activity increased in the 20 min. ACEA reduced the epileptiform activity starting in the 50th min. apelin-13 and ACEA administration in effective doses decreased epileptiform activity. The non-effective doses of AM-251, apelin-13 and effective dose of ACEA decreased the epileptiform activity in the 50 min. Application of non-effective doses of apelin and AM-251 together does not induce any additional proconvulsant activity, and CB1 receptor agonist, ACEA reversed the proconvulsant activity of apelin-13. These results suggest that they utilize different receptors to begin their own effects by increasing intracellular Ca2+ in epilepsy. Considering that apelin-13 is an endogenous substance known for its neuroprotective properties, the proconvulsant effect of apelin-13 in the presented study is remarkable.

Topics

  • Apelin-related biomedical research

Primary topic Apelin-related biomedical research

Authors

  1. FATMA BANU AYÇIK ONDOKUZ MAYIS ÜNİVERSİTESİ
  2. MUSTAFA AYYILDIZ
  3. ERDAL AĞAR